Synta Pharmaceuticals7月 2026のための市場シェア分析

madrigal pharmaceuticals, inc. (nasdaq: mgdl) is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.